Sale!

DNAAF5 Gene Primary Ciliary Dyskinesia Type 18 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The DNAAF5 Gene Primary Ciliary Dyskinesia Type 18 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, aimed at detecting mutations in the DNAAF5 gene, which are linked to Primary Ciliary Dyskinesia (PCD) Type 18. PCD is a rare genetic disorder that affects the cilia, tiny hair-like structures that line the airways, reproductive system, and other parts of the body. Mutations in the DNAAF5 gene disrupt the normal function of cilia, leading to a range of symptoms including chronic respiratory infections, fertility issues, and situs inversus. The test, priced at 4400 AED, involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific genetic alterations associated with the condition. This test is crucial for individuals with a family history of PCD or those exhibiting symptoms, as it provides a definitive diagnosis, enabling targeted management and treatment strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DNAAF5 Gene Primary ciliary dyskinesia type 18 Genetic Test

Components: DNAAF5 Gene Primary ciliary dyskinesia type 18 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Ear Nose Throat Disorders

Doctor: ENT Doctor

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB17

Test Details

The DNAAF5 gene is associated with primary ciliary dyskinesia (PCD) type 18. PCD is a rare genetic disorder that affects the structure and function of cilia, which are hair-like structures on the surface of cells that help with movement and signaling. In PCD, the cilia are abnormal or absent, leading to a variety of symptoms including chronic respiratory infections, hearing loss, and infertility.

NGS genetic testing refers to Next Generation Sequencing, a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire genome. NGS genetic testing can be used to identify mutations or variations in the DNAAF5 gene that are associated with PCD type 18. This type of testing can help with the diagnosis of PCD and provide valuable information for genetic counseling and management of the condition.

It’s important to note that genetic testing should be done under the guidance of a healthcare professional or genetic counselor, as they can help interpret the results and provide appropriate recommendations based on the individual’s specific situation.

Test Name DNAAF5 Gene Primary ciliary dyskinesia type 18 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GJB2 Gene Deafness with keratopachydermia and constrictions of fingers and toes NGS Genetic DNA Test gene GJB17
Test Details

The DNAAF5 gene is associated with primary ciliary dyskinesia (PCD) type 18. PCD is a rare genetic disorder that affects the structure and function of cilia, which are hair-like structures on the surface of cells that help with movement and signaling. In PCD, the cilia are abnormal or absent, leading to a variety of symptoms including chronic respiratory infections, hearing loss, and infertility.

NGS genetic testing refers to Next Generation Sequencing, a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or even the entire genome. NGS genetic testing can be used to identify mutations or variations in the DNAAF5 gene that are associated with PCD type 18. This type of testing can help with the diagnosis of PCD and provide valuable information for genetic counseling and management of the condition.

It’s important to note that genetic testing should be done under the guidance of a healthcare professional or genetic counselor, as they can help interpret the results and provide appropriate recommendations based on the individual’s specific situation.